Relations between patients' characteristics and PRUa
| Clinical and Laboratory Variables | P | PRU |
|---|---|---|
| Sex (male) | <.001 | 244 ± 68 vs 291 ± 78 |
| Age (younger than 65 years) | .028 | 268 ± 80 vs 295 ± 72 |
| Body weight (≥60 Kg) | .031 | 267 ± 78 vs 292 ± 76 |
| CPG medication (≥7 days) | .003 | 230 ± 96 vs 283 ± 74 |
| Combination antiplatelet medication (yes) | .175 | 263 ± 83 vs 281 ± 76 |
| Hypertension (no) | .745 | 275 ± 78 vs 278 ± 78 |
| Diabetes mellitus (yes) | .184 | 251 ± 99 vs 279 ± 76 |
| Statin use (no) | .198 | 274 ± 78 vs 293 ± 77 |
| Smoking status (current or past smoker) | .071 | 256 ± 73 vs 282 ± 79 |
| Alcohol intake (yes) | .157 | 260 ± 76 vs 280 ± 78 |
| Hematocrit level (≥38%) | .008 | 263 ± 73 vs 293 ± 81 |
| Platelet count (<227 × 103/μL) | .562 | 274 ± 80 vs 280 ± 76 |
| Total cholesterol level (<200 mg/dL) | .232 | 273 ± 80 vs 288 ± 71 |
| HDL cholesterol level (≥40 mg/dL) | .225 | 275 ± 79 vs 292 ± 69 |
| LDL cholesterol level (≥130 mg/dL) | .608 | 273 ± 75 vs 280 ± 78 |
| Triglyceride level (<200 mg/dL) | .091 | 274 ± 77 vs 299 ± 72 |
| Procedure-related thromboembolism (no) | .061 | 274 ± 78 vs 318 ± 54 |
a A group of patients denoted within the parentheses showed decreased residual platelet activity.